Effects of acute and chronic administration of selective monoamine re-uptake inhibitors in the rat forced swim test

Psychoneuroendocrinology

Volumn 28, Issue 3, 2003, Pages 332-347

  Kelliher, P ^a   Kelly, J P ^a   Leonard, B E ^a   Sanchez C ^b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b H LUNDBECK A S   (Denmark)

Author keywords

Antidepressant; Behaviour; Endocrine; Forced swim test; Monoamine re uptake inhibitors; Stress

Indexed keywords

5 CHLORO 1 (3 DIMETHYLAMINOPROPYL) 1 (4 FLUOROPHENYL)PHTHALAN; ANTIDEPRESSANT AGENT; CORTICOSTERONE; CORTICOTROPIN DERIVATIVE; LU 10134C; MESSENGER RNA; MONOAMINE; NORADRENALIN UPTAKE INHIBITOR; PREPROOPIOMELANOCORTICOTROPIN; SEROTONIN UPTAKE INHIBITOR; TALSUPRAM; UNCLASSIFIED DRUG;

ADENOHYPOPHYSIS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; FORCED SWIMMING TEST; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS;

EID: 0037388970     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(02)00026-4     Document Type: Article

References (62)

1. Abel E.L. Physiological effects of alarm chemosignal emitted during the forced swim test. J. Chem. Ecol. 19:1993;2891-2901.
2. Armario A., Garcia-Marquez C. Tricyclic antidepressants activate the pituitary-adrenal axis in the rat. Tolerance to repeated drug administration. Eur. J. Pharmacol. 140:1987;239-244.
3. Armario A., Gavalda A., Marti O. Forced swimming test in rats: effect of desipramine administration and the period of exposure to the test on struggling behavior, swimming, immobility and defecation rate. Eur. J. Pharmacol. 158:1988;207-212.
4. Armario A., Garcia-Marquez C., Giralt M. Previous chronic chlorimipramine treatment did not modify some physiological responses to acute and chronic stress in rats. Psychopharmacology. 94:1988;217-220.
5. Bigler A.J., Bogeso K.B., Toft A. Quantitative structure-activity relationships in a series of selective 5-HT uptake inhibitors. Eur. J. Med. Chem. 12:1977;289-295.
6. Borsini F. Role of the serotonergic system in the forced swimming test. Neurosci. Biobehav. Rev. 19:1995;377-395.
7. Borsini F., Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology. 94:1988;147-160.
8. Brady L.S., Whitfield H.J.J., Fox R.J., Gold P.W., Herkenham M. Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications. J. Clin. Invest. 87:1991;831-837.
9. Brady L.S., Gold P.W., Herkenham M., Lynn A.B., Whitfield H.J.J. The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications. Brain Res. 572:1992;117-125.
10. Carlsson A., Fuxe K., Hamberger B., Malmfors T. Effect of a new series of bicyclic compounds with potential thymoleptic properties on the reserpine-resistant uptake mechanism of central and peripheral monoamine neurones in vivo and in vitro. Br. J. Pharmacol. 36:1969;18-28.
11. Centeno V.A., Volosin M. Chronic treatment with desipramine: effect on endocrine and behavioral responses induced by inescapable stress. Physiol. Behav. 62:1997;939-944.
12. Cervo L., Grignaschi G., Samanin R. Role of central serotonergic neurons in the effect of sertraline in rats in the forced swimming test. Eur. J. Pharmacol. 196:1991;217-222.
13. Chaouloff F. Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res. Rev. 18:1993;1-32.
14. Connor T.J., Kelly J.P., Leonard B.E. Forced swim test-induced endocrine and immune changes in the rat: effect of subacute desipramine treatment. Pharmacol. Biochem. Behav. 59:1998;171-177.
15. Danysz W., Plaznik A., Kostowki W., Malatynska E., Jarbe T.U.C., Hiltunen A.J., Archer T. Comparison of desipramine, amitryptiline, zimelidine, and alaproclate in six animal models used to investigate antidepressant drugs. Pharmacol. Toxicol. 62:1988;42-50.
16. Delbende C., Delarue C., Lefebvre H., Tranchand Bunel D., Szafarczyk A., Mocaer E., Kamoun A, Jegou S., Vaudry H. Glucocorticoids, transmitters and stress. Br. J. Psychiatr. 160 (Suppl. 15):1992;24-34.
17. Delbende C., Bunel D.T., Tarazzo G., Grino N.M., Oliver C., Mocaer E., Vaudry H. Effect of chronic treatment with the antidepressant tianeptine on the hypothalamus-pituitary-adrenal axis. Eur. J. Pharmacology. 251:1994;287-292.
18. Detke M.J., Lucki I. Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: The effects of water depth. Behav. Brain Res. 73:1996;43-46.
19. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology. 121:1995;66-72.
20. Detke M.J., Johnson J., Lucki I. Acute and chronic antidepressant treatment in the rat forced swimming test model of depression. Exp. Clin. Psychopharmacol. 5:1997;107-112.
21. Duncan G.E., Knapp D.J., Carson S.W., Breese G.R. Differential effects of chronic antidepressant treatment on swim stress- and fluoxetine-induced secretion of corticosterone and progesterone. J. Pharmacol. Exp. Ther. 285:1998;579-587.
22. Fuxe K., Ogren S.O., Everitt B.J., Agnati L.F., Eneroth P., Gustafsson J.A., Jonsson G., Skett P., Holm A.C. The effect of antidepressant drugs of the imipramine type on various monoamine systems and their relation to changes in behaviour and neuroendocrine function. Garantinni S. Depressive Disorders. 1978;67-80 Schattauer, New York.
23. Garcia-Garcia L., Fuentes G.A., Manzanares J. Differential 5-HT-mediated regulation of stress-induced activation of proopiomelanocortin (POMC) gene expression in the anterior and intermediate lobe of the pituitary in male rats. Brain Res. 772:1997;115-120.
24. Gomez F., Grauges P., Martin M., Armario A. The effect of chronic administration of antidepressants on the circadian pattern of corticosterone in the rat. Psychopharmacology. 140:1998;127-134.
25. Hansen H.H., Sanchez C., Meier E. Neonatal administration of the selective serotonin reuptake inhibitor Lu 10-134-C increases forced swimming-induced immobility in adult rats: a putative animal model of depression? J. Pharmacol. Exp. Ther. 283:1997;1333-1341.
26. Harbuz M.S., Lightman S.L. Responses of hypothalamic and pituitary mRNA to physical and psychological stress in the rat. J. Endocrinol. 122:1989;705-711.
27. Hilakivi-Clarke L.A., Goldberg R. Effect of tryptophan and serotonin uptake inhibitors on behavior in male transgenic transforming growth factor alpha mice. Eur. J. Pharmacol. 237:1993;101-108.
28. Hollt V., Przewlocki R., Haarmann I., Almeida O.F., Kley N., Millan M.J., Herz A. Stress-induced alterations in the levels of messenger RNA coding for proopiomelanocortin and prolactin in rat pituitary. Neuroendocrinology. 43:1986;277-282.
29. Holsboer F., Barden N. Antidepressants and hypothalamic-pituitary- adrenocortical regulation. Endocrin. Rev. 17:1996;187-205.
30. Jensen J.B., Jessop D.S., Harbuz M.S., Mørk A., Sánchez C., Mikkelsen J.D. Acute and long-term treatments with the selective serotonin reuptake inhibitor citalopram modulate the HPA axis activity at different levels in male rats. J. Neuroendocrinol. 11:1999;465-471.
31. T1A receptor activation. J. Neuroendocrinol. 13:2001;887-893.
32. Kelliher P., Connor T.J., Kelly J.P., Leonard B.E. Novel correlates of re-uptake inhibitor activity in the rat forced swim test. J. Psychopharmacol. 12:1998;A27.
33. Kelly J.P., Leonard B.E. The effect of tianeptine and sertraline in three animal models of depression. Neuropharmacology. 33:1994;1011-1016.
34. Kitayama I., Janson A.M., Cintra A., Fuxe K., Agnati L.F., Ogren O.S., Harfstrand A., Eneroth P., Gustafsson J.A. Effects of chronic imipramine treatment on glucocorticoid receptor immunoreactivity in various regions of the rat brain: Evidence for selective increases of glucocorticoid receptor immunoreactivity in the locus coeruleus and in 5-hydroxytryptamine nerve cell groups of the rostral ventromedial medulla. J. Neur. Transm. 73:1988;191-203.
35. Kulkarni S.K., Mehta A.K. Purine nucleoside-mediated immobility in mice. Psychopharmacology. 85:1985;460-463.
36. Larsen P.J., Mau S.E. Effect of acute stress on the expression of hypothalamic messenger ribonucleic acids encoding the endogenous opioid precursors preproenkephalin A and proopiomelanocortin. Peptide. 15:1994;783-790.
37. Lopez-Calderon A., Ariznavarreta C., Chen C.L. Influence of chronic restraint stress on pro-opiomelanocortin mRNA and beta-endorphin in the rat hypothalamus. J. Mol. Endocrin. 7:1991;197-204.
38. Lopez-Rubalcava C., Lucki I. Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test. Neuropsychopharmacology. 22:2000;191-199.
39. Maj J., Rogoz Z., Skuza G., Sowinska H. Effects of MK-801 and antidepressant drugs in the forced swimming test in rats. Eur. Neuropsychopharmacol. 2:1992;37-41.
40. Martinez J., Potier P. Peptide hormones as precursors. Trends Pharmacol. Sci. 7:1986;139-147.
41. Mezey E., Reisine T.D., Palkovits M., Brownstein M.J., Axelrod J. Direct stimulation of beta-adrenergic receptors in rat anterior pituitary induces the release of adrenocorticotropin in vivo. Proc. Nat. Acad. Sci. USA. 80:1983;6728-6731.
42. Morrill A.C., Wolfgang D., Levine M.A., Wand G.S. Stress alters adenylyl cyclase activity in the pituitary and frontal cortex of the rat. Life Sci. 53:1993;1719-1727.
43. Page M.E., Detke M.J., Dalvi A., Kirby L.G., Lucki I. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology. 147:1999;162-167.
44. Plaznik A., Kostowki W. Modification of behavioral response to intra-hippocampal injections of noradrenaline and adrenoceptor agonists by chronic treatment with desipramine and citalopram: Functional aspects of adaptive receptor changes. Eur. J. Pharmacol. 117:1985;245-252.
45. Plaznik A., Kostowki W. The effects of antidepressants and electroconvulsive shocks on the functioning of the mesolimbic dopaminergic system: A behavioural study. Eur. J. Pharmacol. 135:1987;389-396.
46. Plotsky P. Facilitation of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection. Endocrinology. 121:1987;924-930.
47. Porsolt R.D., Anton G., Blavet N., Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 47:1978;379-391.
48. Porsolt R.D., Bertin A., Blavet N., Deniel M., Jalfre M. Immobility induced by forced swimming in rats: effects of agents that modify central catecholamine and serotonin activity. Eur. J. Pharmacol. 57:1979;201-210.
49. Przegalinski E., Budziszewska B., Siwanowicz J. The effect of repeated treatment with antidepressant drugs or electroconvulsive shock on the phenylephrine-induced elevation of the plasma corticosterone concentrations in rats. Pol. J. Pharmacol. Pharm. 43:1991;15-20.
50. Reichlin S. Neuroendocrinology. Wilson J.D., Foster D.W. Williams Textbook of Endocrinology, eighth ed. 1992;135-219 W.B. Saunders Company, Philadelphia.
51. Reisine T.D., Heisler S., Hook V.Y., Axelrod J. Activation of beta 2-adrenergic receptors on mouse anterior pituitary tumor cells increases cyclic adenosine 3':5'-monophosphate synthesis and adrenocorticotropin release. J. Neurosci. 3:1983;725-732.
52. Reneric J.-P., Lucki I. Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test. Psychopharmacology. 136:1998;190-197.
53. Reul J.M.H.M., Stec I., Soder M., Holsboer F. Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology. 133:1993;312-320.
54. Reul J.M.H.M., Labeur M.S., Grigoriadis D.E., De Souza E.B., Holsboer F. Hypothalamic-pituitary-axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide. Neuroendocrinology. 60:1994;509-519.
55. Saphier D., Feldman S. Adrenoceptor specificity in the central regulation of adrenocortical secretion. Neuropharmacology. 28:1989;1231-1237.
56. Shimoda K., Yamada N., Ohi K., Tsujimoto T., Takahashi K., Takahashi S. Chronic administration of tricyclic antidepressants suppresses hypothalamic-pituitary-adrenocortical activity in male rats. Psychoneuroendocrinology. 13:1988;431-440.
57. Stone E.A., Trullas R., Platt J.E. The effect of acute and chronic administration of desmethylimipramine on response to stress in rats. Progr. Neuropsychopharmacol. Biol. Psychiatr. 8:1984;587-592.
58. Torpy D.J., Grice J.E., Hockings G.I., Crosbie G.V., Walters M.M., Jackson R.V. The effect of desipramine on basal and naloxone-stimulated cortisol secretion in humans: Interaction of two drugs acting on noradrenergic control of adrenocorticotropin secretion. J. Clin. Endocrinol. Metab. 80:1995;802-806.
59. Tozawa F., Suda T., Yamada M., Ushiyama T., Tomori N., Sumitomo T., Nakagami Y., Demura H., Shizume K. Insulin-induced hypoglycemia increases proopiomelanocortin messenger ribonucleic acid levels in rat anterior pituitary gland. Endocrinology. 122:1988;1231-1235.
60. Weiss J.M., Goodman P.A., Losito B.G., Corrigan S., Charry J.M., Bailey W.H. Behavioral depression produced by an uncontrollable stressor: relationship to norepinephrine, dopamine, and serotonin levels in various regions of rat brain. Brain Res. Rev. 3:1981;167-205.
61. Weiss J.M., Cierpial M.A., West C.H. Selective breeding of rats for high and low motor activity in a swim test: toward a new animal model of depression. Pharmacol. Biochem. Behav. 61:1998;49-66.
62. Wu P., Childs G.V. Changes in rat pituitary POMC mRNA after exposure to cold or a novel environment, detected by in situ hybridization. J. Histochem. Cytochem. 39:1991;843-852.